Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention

OBJECTIVE: The comparative efficacy and safety of prasugrel and ticagrelor in patients with myocardial infarction (MI) treated with percutaneous coronary intervention (PCI) remain unclear. We aimed to investigate the association of treatment with clinical outcomes. METHODS: In the SWEDEHEART (Swedis...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Heart
Autori principali: Venetsanos, Dimitrios, Träff, Erik, Erlinge, David, Hagström, Emil, Nilsson, Johan, Desta, Liyew, Lindahl, Bertil, Mellbin, Linda, Omerovic, Elmir, Szummer, Karolina Elisabeth, Zwackman, Sammy, Jernberg, Tomas, Alfredsson, Joakim
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2021
Soggetti:
Coronary Artery Disease
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8257560/
https://ncbi.nlm.nih.gov/pubmed/33712510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/heartjnl-2020-318694
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi